MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202641077221 A) filed by Dr. V. Dooslin Mercy Bai; Asmith. S. Revensia; Kondra Ruhma; and Heena Thasneem. M on June 23, 2026, for Ai Driven Multi-Parameter Wearable For Cardiotoxicity Prediction.
Inventors include Dr. V. Dooslin Mercy Bai; Asmith. S. Revensia; Kondra Ruhma; and Heena Thasneem. M.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention discloses an Al-enabled multi-parameter wearable sensor patch for early prediction of chemotherapy-induced cardiotoxicity in cancer patients. The system integrates ECG monitoring with physiological sensors for measuring heart rate variability, blood oxygen saturation, respiratory rate, skin temperature, and physical activity. The collected data are processed using embedded electronics and transmitted wirelessly to a cloud-based analytics platform. Artificial intelligence and machine learning algorithms analyze physiological trends and cardiac biomarkers to identify early signs of cardiotoxicity and generate predictive risk scores. The invention further includes automated alert mechanisms for healthcare providers, enabling timely clinical intervention and personalized patient management. The wearable patch provides continuous, non-invasive, and remote monitoring capabilities, thereby improving patient safety, reducing hospitalization, and enhancing treatment outcomes. The system offers a comprehensive solution for proactive cardiovascular surveillance during chemotherapy and supports telemedicinebased oncology care.
Disclaimer: Curated by HT Syndication.
